News & Updates

Noninvasive brain stimulation (NIBS) plus psychosocial intervention is effective in alleviating moderate to severe depression, but not minimal to mild depression, according to results of a meta-analysis.

Patients with major depressive disorder (MDD) generally achieve satisfactory treatment response with antipsychotic treatment, used either as monotherapy or adjunctively, a meta-analysis has shown. However, this benefit comes with an increased risk of adverse events.

Around 75 percent of patients on clozapine develop treatment-induced gastrointestinal hypomotility (CIGH), which contributes to substantial risks of serious morbidity and mortality, a study reports.

Though with an overall downward trend over the last 10 years, the rates of suicides and suicide attempts vary substantially across different seasons, reports a recent France study.

The use of the oral GnRH antagonist linzagolix in patients with heavy menstrual bleeding (HMB) due to uterine fibroids induced multiple benefits including improved haemoglobin (Hb) levels, health-related quality of life (HRQoL), and mood, analysis of the PRIMROSE 1 and 2 trials showed.

The application of multiple serum biomarkers appears to facilitate better prediction of suicidal behaviour in outpatients receiving treatment for depressive disorders, a study has found.

High levels of loneliness among elderly adults increase the likelihood of reporting pain, fatigue, depression, and the cluster of all three symptoms, reports a recent study.

Using wearable devices helps improve study completion among people with eating disorders, as well as boosts their engagement with a smartphone app intervention, according to a recent study. Greater program retention, in turn, may lead to better outcomes.